What's Happening

SummitReheis knows the global market—and we stay ahead of the curve by engaging with our customers at major industry events around the world, expanding our understanding, and introducing new solutions to meet your needs.


Apr 4th - 6th, 2017
In-Cosmetics Global
United Kingdom
Booth L30
May 2nd - 3rd, 2017
NYSCC Suppliers' Day
New York
United States
Booth 1349
Sep 20th - 21st, 2017
In-Cosmetics Latin America
Sao Paulo
Booth E50
Oct 11th - 12th, 2017
In-Cosmetics North America
New York
United States
Booth F29
Oct 31st - Nov 2nd, 2017
In-Cosmetics Asia
Booth F70


December 5th, 2016

SummitReheis UK Gains FDA Certification

SummitReheis is pleased to announce that Alembic Manufacturing Limited, its joint venture partner in the United Kingdom, has been successfully registered as a Drug Establishment with the United States Food and Drug Administration, and the initial registration is current through December 31, 2017.  Alembic produces USP quality antiperspirant actives which are supplied by SummitReheis to its customers in the UK and other European markets.    

Alembic is a quality leader which is also ISO 9001 certified and accredited by the EFfci (European Federation for Cosmetic Ingredients) for the GMP production of cosmetic ingredients.  It has been producing antiperspirant actives in the UK since 1990 and the Joint Venture Agreement with SR was originally established in 2003.  Like SR’s other facilities in the United States, Germany, and China, Alembic is also an environmental leader and is registered with the UK Environment Agency as a low impact site equivalent to a zero discharge plant in United States regulatory terms. 

Please direct inquiries to Joe Andriac (jandriac@summitresearchlab.com) or Philip Klepak (pklepak@summitresearchlabs.com).